Evaluation of Insulin Glargine and Exenatide: A Randomized Clinical Trial With Continuous Glucose Monitoring and Ambulatory Glucose Profile Analysis.
Phase of Trial: Phase III
Latest Information Update: 31 May 2017
At a glance
- Drugs Exenatide (Primary) ; Insulin glargine (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 01 May 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 11 Apr 2013 Planned end date changed from 1 Aug 2013 to 1 May 2013 as reported by ClinicalTrials.gov.